Supplementary Figure 4.docx (107.44 kB)

Supplementary Figure 4. Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort

figure

posted on 2021-05-20, 08:28 authored by Jean-Philippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux, Christophe Borg, Rosine Guimbaud, Jean-Marc Phelip, Louis-Marie Dourthe, Stefano Kim

Supplementary Figure 4. Overall survival (a) and progression-free survival (b), stratified by prior anti-VGEF therapy.

Funding

Bayer

History

Usage metrics

Read the peer-reviewed publication

Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort

Hepatic Oncology

Keywords

colorectal cancer CORRELATE metastatic multi-kinase inhibitor regorafenib Solid Tumours

Licence

CC BY-NC-ND 4.0